red cell disorders
anemia -> low RBC mass
polycythemia -> high rbc mass
anemia
reduction in o2 transprting capacity
trigger increase of epo production
=> compensatory hyperplasia of erythroid precursors in the bone marrow
rise in BM output
appearance of extrs medullary hematopoiesis
erythropoiesis-CPU-E
from proerythroblast to reticulocyte (still has RNA) -> released into circulation and mature to RBC
clinical symptoms for anemia
Pallor
Tiredness
Lassitude
Fatique
Headaches,dizzines
Weakness
Shortnessofbreath
Somethimes angina pectoris or heartburn
Whan can be causes of anemia
• Blood loss? can also be menstruation
• Decreased production?
• nutrients/BM infiltration/dysplasia
• Increased destruction?
• intra/extravascular
• intra/extracorpuscular
symptoms for aplastic anemia
inflammation and bleeding
symptoms for hemolytic anemia
jaundice
symptoms for magaloblastic anemia
neurological disorders
anemia classification due to haemoglobin content in RBC
Normally haemoglobin content in erythrocyte is 0,8-1,05. This index is named color index (CI).
hyperchromic - CI > 1,05 ( B12 and pholate-deficiency)
hypochromic - CI < 0,8 (iron deficiency)
normochromic - CI is normal (inherited haemolytic anaemias)
anemia classification based on the degree of regeneration
Normally reticulocytes constitute 0.5 to 1.5% of the RBC.
regenerative - normal reticuloctes count (most of anemias)
hyporegenerative - reticuloctes <0.5 (chronic posthemorrhagic)
non-regenerative anemia - reticulocytes are absent (bone marrow aplasia)
hyperregenerative - reticulocytes >1,5 (inherited hemolytic anemias)
regenerative anemia
bone marrow respondes and releases reticulocytes
non regenerative anemia
inadequate respond of bone marrow
low MVC =
microcytic anemia (iron)
normal MVC =
normocytic anemia (anemia of chronic disease)
High MVC =
macrocytic anemia (B12)
varying MVC =
Haemolytic anemia
anemia of blood loss
I. Anemia of blood loss
A. Acute bleeding (hemorrhage)
• •
loss of intravascular volume (cardiovascular colapse, hypovolemic shock – loss exceeds 20%)hemodilution within 2-3 days normocytic, normochromic anemia low E, Hg, Htc high Rtc-> good sign
B. Cronic blood loss
n
sideropenic anemia (storage are gradually
depleted) -> iron related
hemolytic anemia
• Diverse group of disorders that have as a common feature accelerated red cell destruction (hemolysis)
• Hallmark: erythroid hyperplasia
reticulocytosis exstramedullary hematopoiesis
hemolytic anemia common features
low erythrocytes
high EPO
high RTC
hyperbiliruninemia -> unconjugated jaundice
high gallstones
hemosiderosis
splenomegalie
intravascular hemolysis
1. low haptoglobin
2. Hemoglobinemia
3. Hemoglobinuria
4. Hemosiderinuria
5. Methemalbuminemia
hereditary spherocytosis
• inherited defects in red cell membrane sceleton that lead to the formation of spherosytes
• Highly vulnerable to sequestration and destruction in the spleen
spherocytes
Dark red cells
Lack central pallor
Reticulocytosis
Osmotic fragility test
Hypercelular BM
sickecell anemia
AR
mutation in Beta-globin -HgS
hypoxia, hypercapnia, hypertermia
vasooclusive crisis
thalassemia
mutation in globin genens -> decreased synthesis of beta or alpha globin
hypochromic, microcytic anemia
beta thallasemia
mainly point mutaion
– homozygous - thallasemia major • severe anemia, regular blood transfusions
– heterozygous - thallasemia minor • asymptomatic with mild or absent anemia
• T. major manifests postnatally
– Growth retardation
– Sceletal deformities
– blood transfusion (systemic Fe overload)
– Secundary hemosiderosis and hemochromatosis
• Fatal in 2nd or 3th decade of life
alpha thallasemia
mainly caused by deletion
Severity of the disease is proportional to the number of deleted alpha genes
• 4 genes: fetal hydrops, letal in utero
• 1 gene: silent carrier state
G6PD deficiency associated with
transient episodes of intravascular hemolysis
• oxydative injury:
– oxidants are normally inactivated by reduced glutathione (GSH)
– impaired regeneration of GSH in G6PD-deficient cells
– hydrogen peroxid accumulation – Hg denaturation - Heinz
bodies
X-linked
Paroxymal nocurnal hemogloninuria
aquired mut. in PIGA gene
X-linked in erarly hematopoetic progenitor
thrombosis as complication
hemolytic anemia extrinsic abnormalities
I Antibody-mediated hemolitic anemia
1. Autoantibodies
Warm antibody type
Cold antibody type
2. Isohemagglutinins
Transfusion reaction
Rh disease of the newborn
II Infections, toxins
• malaria • snakebite
III Mechanical trauma to red cells
Microangiopathic hemolytic anemia (DIC, SLE, TTP, HUS,
Defective cardiac valve prostheses
Splenomagalia
Marathon racing, bongo drumming...
Immunohemolytic anemia
IgG warm Ab type
1. IgG: active at 37C
2. Erythrophagocytosis,spherocytes
Idiopathic (> 60%)
Secundary: CLL, SLE, drugs
Moderate splemomegaly
Chronic mild anemia
IgM cold Ab type
Low affinity IgM Below 30C
2. limphoid neoplasms, mycoplazma infection, IM
3. Distal parts of the body
4. E +IgM+ complement– extravascular hemolysis (liver, spleen)
5. Raynaud phenomenon
Iron deficiency anemia
• Nutritional deficiency of iron
• Pathogenesis:
– Low intake, poor bioavailability (vegetarian diets)
– Malapsorption
– Chronic blood loss
– Increase demands (pregnancy, infancy)
Anemia of chronic inflammation
causes
chronic inflammatory disease
infection s(TBC)
noninfectious (RA;SLE)
Malignant disease
Pathogenesis-
• Key regulatory protein - hepcidin which is produced by liver
> High levels of production are encouraged by pro- inflammatory cytokines. especiallyI L -6 .
• Hepcidin binds to ferroportin on the membrane of iron exporting cells, and thereby inhibiting the export of iron from these cells into the blood
Iron remain trapped inside the cells in the form of ferritin, levels of which are therefore normal or high in the tace ot significant anemia
Megaloblastic anemia
• Stems from metabolic defects that lead to inadequate biosyntesis of thimidine
• Folic acid and B12 : essential factors
Abnormalities in rapidly dividing cells
Maturation derangement, apoptosis
Ineffective hematopoiesis
clinical features od Megaloblastic anemia
• Onset - insidious/ gradually progressive sign and symptoms of anemia
• Mildly jaundice- excess breakdown of hb due to increase ineffective erythropoiesis
• Glossitis, angular stomatitis, mild symptoms of malabsorption with loss of weight
• Neuropathy (severe B12 deficiency)
• Neural tube defect in fetus (eg: encephaly, spina bifida)
• Increased melanin pigmentation
aplastic anemia
Disorder of multipotent myeloid stem cells
BM failure with pancytopenia
Exposures to toxins and radiation
Reactions to drugs and viruses
Inherited defects in telomerase and DNA repair
Myelophthisic anemia
Anemia is caused extensive infiltration of the BM
Metastatic carcinoma (lung, breast, prostate)
Granulomatous disease
Lipid-storage disease
Osteopetrosis
MF
Polycytemia
high levels of erythrocytes
classification of Polycytemia
relative: Reduced plasma volume (hemoconcentration)
absolute
primary: - abnormal proliferation of myeloid stem cells (PV) - inherited activating mutations in the
erythropoietin receptor
secondary: (increased erythropoietin levels)
– Adaptive: lung disease, cyanotic heart disease...
– Paraneoplastic: erythropoietin secretingtumors(RCC,HCC...)
Disseminated intravascular coagulation (DIC)
Complication of a wide variety of disorders
Caused by the systemic activation of coagulation
Results in the formation of thrombi throughout the microcirculation
complications with DIC
obstetric complications
tissue injury
infections
neoplasm
miscellaneous
Thrombocytopenia
• Isolated thrombocytopenia: – bleeding tendency – normal coagulation tests
– pts counts 20.000-50.000: increased risk of posttraumatic bleeding
– below 5000: risk of spontaneous bleeding
Von Willebrand disease
• Autosomal dominant disorder caused by mutations in vWF
• large protein that promotes the adhesion of platelets to subendothelial collagen
• typically causes a mild to moderate bleeding disorder resembling that associated with thrombocytopenia
hemophilia A
• X-linked recessive disorder caused by reduced factor VIII activity
Laboratory terms used with respect to the populaIon of erythrocytes:
Mean corpuscular volume (MCV): average volume of a red blood cell
Mean corpuscular hemoglobin (MCH): average content (mass) of hemoglobin per cell
Mean corpuscular hemoglobin concentra>on (MCHC): average concentra>on of hemoglobin in a given
volume of packed erythrocytes
Red cell distribu>on width (RDW): coeecient of varia>on of red blood cell volume and a measure of
anisocytosis
leukopenia
Lymphopenia (immunodeficiency disease, HIV, corticosteroids)
Neutropenia/agranulocytosis reduction in the number of granulocytes in blood risk of fatal bacterial and fungal infection (< 500 cells/μL)
The underlying mechanisms:
decreased granulocyte production
BM hypoplasia, leukemia, BM infiltration
increased granulocyte destruction
immune-mediated injury, infections, splenomegaly
morphology of neutropenia
Depend on the underlying cause
compensatory hypercellularity
decreased numbers of granulocytic precursors (e.g. drug exposure)
reduced all lineages
clinical features of neutropenia
Infections: take the form of ulcerating, necrotizing lesions of the gingiva, floor of the mouth, bucall mucosa
Agranulocytic angina
Systemic symptoms
Sepsis
Th: granulocyte colony-stimulating factor (G-CSF)
neutrophilia
acute bacterial infections, sterile inflammation
eosinophilia
allergic disorders, parasite infestation, drug reaction, MH
basophilia
Myeloproliferative neoplasm
Monocytosis
chronic infections, SLE
Lymphocytosis
viral infections, chronic immunologic stimulation
infectious mononucleosis
EBV
asymptomatic unfections in children
symptomatic infections in adults
fever, sore throat
generalysed lymphadenitis
Pathogenesis of infectious mononucleosis
direct oral contact
infection of B cells (3tonsills and adenoids): lytic and latent
host T cell response (CD8 T cells – atypic ly) – controles the proliferation of EBV- infected B cells
IgM Ab
shift to IgG Ab (persist for life)
impaired T cell immunity: high risk to EBV-driven B cell proliferation
lymphadenopaty
lymph node enlargement
any immune response againts foreign Ag , metastasis, lymphomas
lymphadentitis
Infections (acute, chronic)
acute nonspecific lymphadenitis
Isolated to a group of nodes draining a local infection Generalized: systemic infections, inf lammatory conditions
LN: swollen, grey-red, engorged, painful Abscess formation: tender, fluctuant ln Overlying skin: red, draining sinuses
large germinal centers
scarring
etiology of chronic nonspecific lymphadenitis
microorganisms
immunodeficiency
Autoimmune disease
Foreign bodies
tumors
3 patterns of chronic nonspecific lymphadenitis
follicular hyperplasia
paracortical hyperplasia
sinus histiocytosis
Folicular hyperplasia
occures with activation of B cells -> germinal center
RA, toxoplasmosis, early HIV
DIF. DG.: FOLLICULAR LYMPHOMA
Distension and prominence of the lymphatic sinusoids
Infiltrate of macrophages (histiocytes)
Hypertrophy of lining endothelial cells
lymph nodes draining cancers
Paracortical hyperplasia
Immune reaction involving the T cell region
activated parafollicular T cells transform into large
proliferative immunoblasts
Viral infection (EBV), drugs, vaccinations (smallpox)
Cat-scrat disease
Self-limited lymphadenitis
Bartonella hensellae
Disease of childhood (90%)
skin lesion
lymph node enlagemnet (axilla,neck)
Iregular stellate necrotizing granulomas
Heamophagocytic lymphohistiocytosis
proinf lammatory exposures
trigger activation of macrophages throughout the body
inherited defects
killer Ly (CD8, NK) – unable to kill theit targets (virus infected cells)
excessive release of cytokines that activates macrophages
Systemic inf lammatory response sy (SIRS)
BM: macrophages phagocytosing E, plt, and nucleated cells
High ferritin level
BM transplantation
fever
splenomegaly
Pancytopenia
Lymphoid neoplasm
leukemias
lymphomas
hodgkin
nonhogkin
Precursor B and T cell neoplasms Acute lymphoblastic leukemia/lymphoma
Accumulation of immature, nonfunctional lymphoblasts:
pre-B or pre-T cell
Childhood leukemias :
85% B-ALLs (peaks of incidence at age of 3) 90% of childs prognosis very good
Adolescents: T -ALLs (as a thymic LL/ALLs)
Immunophenotype: TdT+(>95%)
Precursor B and T cell neoplasms Acute lymphoblastic leukemia/lymphoma clinical features:
Aggressive disease
Symptomes related to depression
of marrow function
Mass effects caused by neoplastic infiltration
Central nervous system manifestation (meningeal spread)
Aggressive chemotherapy
95% children obtain a remission
Factors associated with a worse prognosis:
age younger then 2 ys (MLL)
presentation in adolescence or adulthood
PB count > 100.000
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
The most common leukemia of adults in the Western world
Peripheral blood involvement (dif.dg. CLL vs SLL) PB >5000 cells/μL - CLL
very very Indolent, slowly growing tumor
Increased tumor cell survival (bcl2)
CLL causes immune dysregulation Accumulation of CLL/SLL cells suppress normal B cell function At (hypogammaglobulinemia) 15% develops autoAt againts E and Plt
Immunophenotype: + CD5, CD20
Follicular lymphoma
Constitutes 40% of the adult NHLs
older than 50 ys(males/females)
Painless, generalized
lymphadenopathy
BM involved 80%
LN: nodular proliferation
Mentle cell lymphoma
> 50 ys, males
median survival 4-6 ys
cells resembling the naive B cells in the mantle zones
fatique, lymphadenopathy
manifests with advanced disease involving LN (diffuse or nodular pattern), BM and extranodal sites (GIT)
t(11,14): fuses cyclin D1 gene to the IgH lokus
Extranodal marginal zone lymphoma
Indolent B tumor
stomach, salivary glands, small and large bowel, lungs, breast, orbit (sustained by chronic inflammation)
clonal epithelial infiltration
small aggregates: lymphoepithelial
lesions
Th: excision followed by RTh
Diffuse large B cell lymphoma
the most common type of lymphoma in adults
any age (median 60 ys), 15% childhood lymphomas
1/3 bcl-6 rearrangement, 1/3 t(14,18; bcl-2), MYC gene translocation
de novo/Rihter
Rapidly enlarging mass at one or several sites
Extranodal presentation is common O
Liver, spleen, BM – rare
Subtypes of Diffuse large B cell lymphoma
EBV-assoiated diffuse large B cell lymphomas -> AIDS iatrogenic immunosuperssion
Mediastinal large b cell lymphoma -> young women, spred to CNS and abdominal viscera
Primary effusion lymphoa -> HV8, pleural cavity, pericardium, peritoneum
Burkitt lymphoma
Fastest growing human tumor
Children, young adults
Extranodal sites
Leukemic presentation
Endemic (maxillary or mandibullary masses)
Sporadic (abdominal tumors: bowel, retroperitoneum, ovaries) Immunodefficiency related (AIDS)
plasma cell neoplasm
Neoplastic plasma cells that secrete a monoclonal Ig or Ig fragment
Monoclonal immunoglobulin – M protein
Bence-Jones proteinuria – light chains
plasma cell neoplasm clinicopathologic entities
Multiple myeloma
Solitary plasmacytoma
Smoldering myeloma #
MGUS
Primary amyloidosis
Walderstrom macroglobulinemia
Multiple Myeloma
One of the most common lymphoid malignancy
Median age 70 ys, males, median survival 4 to 7 ys
Multifocal destructive skeletal lesions
> 30% plasma cells in BM
Pathologic fractures
Hypercalcemia, metastatic calcification
Electrophoresis – M protein
Bence Jones proteins – urin
Renal dysfunction (myeloma nephrosis), proteinaceous casts
M osteal lesions C Osteomalc.
Defects in humoral immunity (recurrent bacterial infection)
Hodgkinlymphoma
Neoplasm that arises from germinal center B cells
Nonneoplastic inflammatory cell infiltrate
frequent involvement EBV (70% mix cel.)
painless lymphadenopathy
arise in a single lymph node or chain lymph nodes
Spread in the stepwise fashion to anatomiccaly contiguous nodes
B simptoms
bimodal
Classification of hodgkin ymphoma
Nodular lymphocite predominant Hodgkin lymphoma
Classical Hodgkin lymphoma
Nodular sclerosis
Mixed cellularity
Limphocyte rich
Limphocyte depletion
predominant Hodkin lymphoma
Nodular lymphocyte
popcorn cells
classical hodkin lymphoma
nodular sclerosis
The most common (70%)
Males/females
Adolescents and young adults
Prognosis excellent
Collagen bands
Lacunar cells
Lower cervical, supraclavicular and mediastinal LN
Mixed cellularity
The most common form in adults > 50 ys, male predominance
Classic RS cells
Heterogeneous inf lammatory infiltrates
More likely to be disseminated
EBV
WHO classification of myeloid neoplasms
Myeloproliferative neoplasms - MPN
Myelodysplastic syndromes - MDS
Myelodysplastic/myeloproliferative neoplasms – MDS/MPN
Acute myeloid leukaemias - AML
Myeloid and lymphoid neoplasms with neutrophilia and abnormalities of PDGFRA, PDGFRB ili FGFR1
AML
neoplastic cells are blocked at an early stage of myeloid development (blasts
accumulation)
MPN
neoplastic clone continues to undergo terminal differentiation with increased
or dysregulated growth
MDS
disordered and ineffective terminal differentiation, dysplastic BM precursor and PB cytopenia
Zuletzt geändertvor 9 Monaten